Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Baxter InternationalBAX -3.60%67 Equity-to-Asset is 0.31 as of Jun. 2026, which is 24% below its 10-year median of 0.41. GuruFocus rates BAX with a GF Score™ of 67/100 and a GF Value™ of $33.04 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Baxter International ranks worse than 83.24% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Baxter International's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $6,206 Mil. Baxter International's Total Assets for the quarter that ended in Jun. 2026 was $19,791 Mil.
Therefore, Baxter International's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.31.
The historical rank and industry rank for Baxter International's Equity-to-Asset or its related term are showing as below:
BAX'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.2 Med: 0.41 Max: 0.56
Current: 0.31
During the past 13 years, the highest Equity to Asset Ratio of Baxter International was 0.56. The lowest was 0.20. And the median was 0.41.
BAX's Equity-to-Asset is ranked worse than 83.24% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs BAX: 0.31
Baxter International (NYSE:BAX) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Baxter International Equity-to-Asset Related Terms
Baxter International Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Baxter International's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BAX vs ALGN, SOLV, COO: Equity-to-Asset Comparison
For the Medical Instruments & Supplies subindustry, Baxter International's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Baxter International Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Baxter International's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Baxter International's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Baxter International's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Baxter International (BAX) has a Equity-to-Asset of 0.31 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Baxter International and its competitors. This is 24% below median its historical median of 0.41. Over the past decade, Baxter International's Equity-to-Asset has ranged from 0.20 to 0.56. According to the industry distribution chart, Baxter International ranks #710 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 83.2%.
Is Baxter International's Equity-to-Asset too high?
Baxter International's current Equity-to-Asset of 0.31 is 24% below median its 10-year median of 0.41. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 0.56. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Baxter International's value of 0.31 is 51.6% below this industry median. Based on the distribution chart, Baxter International ranks #710 out of 853 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Baxter International has a GF Score™ of 67/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Equity-to-Asset compare to ALGN and SOLV?
According to the Medical Devices & Instruments industry distribution chart, Baxter International ranks #710 out of 853 companies for Equity-to-Asset. This places Baxter International in the lower half of its industry. The industry median Equity-to-Asset is 0.64. Baxter International's value of 0.31 is 51.6% below this benchmark. Historically, Baxter International's own Equity-to-Asset has ranged from 0.20 to 0.56 over the past decade. While the company's 10-year median is 0.41 vs. the industry median of 0.64, Baxter International has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Baxter International's current Equity-to-Asset of 0.31 is 51.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Baxter International and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Baxter International's current Equity-to-Asset is 0.31, which is 24% below median its own 10-year median of 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Based on GuruFocus' analysis, Baxter International (BAX) is currently considered Modestly Undervalued. The stock's GF Value™ is $33.04, compared to a current price of $27.33 — trading 17.3% below its estimated fair value. The current Equity-to-Asset is 0.31, which is 24% below median its 10-year median of 0.41 and 51.6% below the Medical Devices & Instruments industry median of 0.64. Baxter International's overall GF Score™ is 67/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Baxter International (BAX), the current Equity-to-Asset is 0.31 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Baxter International (BAX) Overvalued in 2026?
Based on GuruFocus' analysis, Baxter International stock appears to be undervalued.
The current stock price of $27.33 is trading 17.3% below its estimated GF Value™ of $33.04.
GuruFocus considers Baxter International to be Modestly Undervalued.
Key valuation signals for BAX:
Equity-to-Asset: 0.31 (24% below median its 10-year median of 0.41)
GF Value™: $33.04 vs. price of $27.33 (17.3% below fair value)
Industry Position: 51.6% below the Medical Devices & Instruments median (#710 of 853)
No single metric tells the full story. See the BAX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
67GF Score
Get the complete analysis for BAX
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BAX has been successfully added to your 
